Page last updated: 2024-08-24

mevastatin and cytochrome c-t

mevastatin has been researched along with cytochrome c-t in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gan, YH; Li, SL; Wang, XL; Zhang, S	1

Other Studies

1 other study(ies) available for mevastatin and cytochrome c-t

Article	Year
Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells. Anti-cancer drugs, 2010, Volume: 21, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Adenoid Cystic; Caspase 3; Cell Proliferation; Cytochromes c; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Lovastatin; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Salivary Gland Neoplasms	2010

Article

Year

Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.

Anti-cancer drugs, 2010, Volume: 21, Issue:7

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Adenoid Cystic; Caspase 3; Cell Proliferation; Cytochromes c; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Lovastatin; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Salivary Gland Neoplasms

2010